XML 63 R53.htm IDEA: XBRL DOCUMENT v3.25.2
Stockholders’ Equity (Details) - USD ($)
 1 Months Ended 3 Months Ended 6 Months Ended
Mar. 24, 2025
Mar. 14, 2025
Oct. 25, 2024
May 02, 2024
Dec. 18, 2023
Feb. 24, 2021
Jan. 31, 2025
Oct. 31, 2017
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Dec. 31, 2024
Stockholders’ Equity [Line Items]                            
At the market offering                       $ 1,200,000    
Average price per share (in Dollars per share)                 $ 4.18     $ 4.18    
Preferred stock, shares authorized (in Shares)                 3,000,000     3,000,000   3,000,000
Preferred stock, par value (in Dollars per share)                 $ 0.001     $ 0.001   $ 0.001
Preferred stock outstanding (in Shares)                 0     0   0
Gross proceeds                       $ 517,445    
Preferred stock issued                   $ 18,466,915        
Patent expenses $ 10,000                          
Increasing the shares of common stock issuable (in Shares)           12,500                
Common stock share issued (in Shares)                 3,176,929     3,176,929   129,680
Common stock, par value (in Dollars per share)                 $ 0.001     $ 0.001   $ 0.001
Vesting expense                 $ 473,311     $ 473,311    
Share based payment remaining expenses                       $ 0    
Weighted average vesting term                       0 years    
Option [Member]                            
Stockholders’ Equity [Line Items]                            
Exercisable options (in Shares)                 59     59    
Weighted average exercise price (in Dollars per share)                 $ 40,808,518.64     $ 40,808,518.64    
2017 Equity Incentive Plan [Member]                            
Stockholders’ Equity [Line Items]                            
Issuance of shares under ELOC (in Shares)               2,500,000            
2021 Omnibus Equity Incentive Plan [Member]                            
Stockholders’ Equity [Line Items]                            
Common stock share issued (in Shares)           14,000                
Common stock, par value (in Dollars per share)           $ 0.001                
Stock option exercise percentage           100.00%                
Pearsanta 2023 Plan [Member]                            
Stockholders’ Equity [Line Items]                            
Issuance of shares under ELOC (in Shares)         250,000                  
Common stock, par value (in Dollars per share)         $ 0.001                  
Stock option exercise percentage         100.00%                  
2025 Reverse Split [Member]                            
Stockholders’ Equity [Line Items]                            
Reverse stock split   1-for-250                        
2025 Pearsanta Reverse Split [Member]                            
Stockholders’ Equity [Line Items]                            
Reverse stock split   1-for-60                        
Common Stock [Member]                            
Stockholders’ Equity [Line Items]                            
Issuance of shares under ELOC (in Shares)                   900,116        
Aggregate offering price     $ 35,000,000                      
At the market offering                       $ 0    
Purchase price       $ 150,000,000                    
Common Stock [Member] | Pearsanta 2023 Plan [Member]                            
Stockholders’ Equity [Line Items]                            
Common stock share issued (in Shares)         155,334                  
Common stock, par value (in Dollars per share)         $ 0.001                  
Preferred Stock [Member]                            
Stockholders’ Equity [Line Items]                            
Preferred stock, shares authorized (in Shares)                 3,000,000     3,000,000    
Preferred stock, par value (in Dollars per share)                 $ 0.001     $ 0.001    
Preferred stock outstanding (in Shares)                 29,380     29,380    
Preferred Stock [Member] | Senior Notes [Member]                            
Stockholders’ Equity [Line Items]                            
Preferred stock outstanding (in Shares)                           35,758
Research and Development Expense [Member]                            
Stockholders’ Equity [Line Items]                            
Stock based compensation expense                 $ 0   $ 1,000,000 $ 10,000 $ 6,712,663  
Selling, General and Administrative Expenses [Member]                            
Stockholders’ Equity [Line Items]                            
Stock based compensation expense                     4,095      
ELOC Purchase Agreement [Member]                            
Stockholders’ Equity [Line Items]                            
Issuance of shares under ELOC (in Shares)             46,157              
Commitment fees             $ 2,250,000              
Non-vested Stock Options [Member]                            
Stockholders’ Equity [Line Items]                            
Exercisable options (in Shares)                 181,227     181,227    
Weighted average exercise price (in Dollars per share)                 $ 1.19     $ 1.19    
Vesting expense                 $ 0   $ 4,095 $ 0    
Non-vested Stock Options [Member] | Research and Development Expense [Member]                            
Stockholders’ Equity [Line Items]                            
Share based payment remaining expenses                       $ 0    
Pearsanta Acquisition of Assets [Member]                            
Stockholders’ Equity [Line Items]                            
Issuance of shares under ELOC (in Shares) 200                          
MDNA [Member]                            
Stockholders’ Equity [Line Items]                            
Issuance of shares under ELOC (in Shares)                       30 5  
ELOC [Member]                            
Stockholders’ Equity [Line Items]                            
Net proceeds                       $ 8,560,920    
Price per share (in Dollars per share)                 $ 18.99     $ 18.99    
ELOC [Member] | Common Stock [Member]                            
Stockholders’ Equity [Line Items]                            
Sale of shares (in Shares)                       853,959    
ATM Shares [Member]                            
Stockholders’ Equity [Line Items]                            
Net proceeds                       $ 16,216,915    
Series A-1 Convertible Preferred Stock [Member]                            
Stockholders’ Equity [Line Items]                            
Preferred stock, shares authorized (in Shares)                 22,280     22,280   22,280
Preferred stock, par value (in Dollars per share)                 $ 0.001     $ 0.001   $ 0.001
Preferred stock outstanding (in Shares)                 21,353     21,353   22,071
Shares of convertible preferred stock (in Shares)                 268     268    
Initial conversion price                 $ 308,000     $ 308,000    
Conversion amount                       $ 500    
Series A-1 Convertible Preferred Stock [Member] | Preferred Stock [Member]                            
Stockholders’ Equity [Line Items]                            
Preferred stock outstanding (in Shares)                 21,803     21,803    
Series C-1 Convertible Preferred Stock [Member]                            
Stockholders’ Equity [Line Items]                            
Issuance of shares under ELOC (in Shares)                       2,263    
Shares of convertible preferred stock (in Shares)                 6,110     6,110    
Initial conversion price                 $ 7,027,070     $ 7,027,070    
Preferred stock issued                       $ 3,956,819    
Series C-1 Convertible Preferred Stock [Member] | Preferred Stock [Member]                            
Stockholders’ Equity [Line Items]                            
Preferred stock outstanding (in Shares)                 2,263     2,263    
Pearsanta Series B Preferred Stock [Member]                            
Stockholders’ Equity [Line Items]                            
Preferred stock, par value (in Dollars per share) $ 0.001                          
Series B Preferred Stock [Member]                            
Stockholders’ Equity [Line Items]                            
Preferred stock, shares authorized (in Shares)                 1     1   1
Preferred stock, par value (in Dollars per share) $ 50               $ 0.001     $ 0.001   $ 0.001
Preferred stock outstanding (in Shares)                 0     0   0
Conversion amount                       $ 1,000,000    
Series B Preferred Stock [Member] | Preferred Stock [Member]                            
Stockholders’ Equity [Line Items]                            
Preferred stock outstanding (in Shares)                        
Series B-2 Convertible Preferred Stock [Member]                            
Stockholders’ Equity [Line Items]                            
Preferred stock, shares authorized (in Shares)                 2,625     2,625   2,625
Preferred stock, par value (in Dollars per share)                 $ 0.001     $ 0.001   $ 0.001
Preferred stock outstanding (in Shares)                 2,625     2,625   2,625
Series B-2 Convertible Preferred Stock [Member] | Secured Promissory Note [Member]                            
Stockholders’ Equity [Line Items]                            
Vesting expense                         $ 28,668  
Series B-2 Convertible Preferred Stock [Member] | Preferred Stock [Member]                            
Stockholders’ Equity [Line Items]                            
Preferred stock outstanding (in Shares)                 2,625     2,625    
Series B-2 Convertible Preferred Stock [Member] | Selling, General and Administrative Expenses [Member]                            
Stockholders’ Equity [Line Items]                            
Stock based compensation expense                         $ 28,688